The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model

Experimental Diabesity Research

Volumn 1, Issue 3, 2000, Pages 203-210

  Gleeson, Aine ^a   Owens, Daphne ^a   Collins, Patrick ^b   Johnson, Alan ^b   Tomkin, Gerald H ^a,c,d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

^d NONE   (Ireland)

Author keywords

Apolipoprotein B48; Cholesterol absorption; Cholesterol synthesis; Chylomicron; Diabetes

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B48; CARBON; CHOLESTEROL; CHYLOMICRON; LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CHOLESTEROL INTAKE; EMULSION; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; INTESTINE; INTESTINE ABSORPTION; LYMPH; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REFERENCE VALUE; SPRAGUE DAWLEY RAT;

ANIMALS; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; BLOOD GLUCOSE; CARBON RADIOISOTOPES; CHOLESTEROL; CHOLESTEROL, DIETARY; CHYLOMICRONS; DIABETES MELLITUS, EXPERIMENTAL; EMULSIONS; INTESTINAL ABSORPTION; INTESTINES; LIPOPROTEINS; LYMPH; MALE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0034570331     PISSN: 15438600     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/edr.2000.203     Document Type: Article

References (26)

1. Coutinho, M., Wang, Y., Gerstein, H. C. and Yusuf, S. (1999). The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care, 22, 233-240.
2. Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R. and Holman, R. R. (1998). Risk factors for coronary artery disease in non-insulin-dependent diabetes Mellitus: UK Prospective Diabetes Study (UKPDS: 23). BMJ., 316, 823-828.
3. The Diabetes Control and Complications Trial Research Group (1993). Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl J. Med., 329, 977-986.
4. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
5. Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H. and Packard, C. J. (1995). The West of Scotland Coronary Prevention Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N. Engl. J. Med., 333,1301-1307.
6. Lewis, S. J. et al. (1998). for the CARE Investigators. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Ann. Intern. Med., 129, 681-689.
7. The Scandinavian Simvastatin Survival Study (4S) Group. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383-1389.
8. Pyorala, K., Pedersen, T. R., Kjekshus, J., Fraegerman, A. G., Olsson, A. G. and Thorgeirsson, G. (1997). The Scandinavian Simvastatin Survival Study (4S) Group. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care, 20, 614-620.
9. Devery, R., O'Meara, N., Collins, P., Johnson, A., Scott, L. and Tomkin, G. H. (1987). Comparative study of the rate-limiting enzymes of cholesterol synthesis, esterification a catabolism in the alloxan-induced diabetic rat and rabbit. Comp. Biochem. Physiol., 87b, 697-702.
10. O'Meara, N., Devery, R., Owens, D., Collins, P., Johnson, A. and Tomkin, G. H. (1990). Cholesterol metabolism in the alloxan-induced diabetic rabbit. Diabetes, 39, 626-633.
11. Feingold, K. R., Wilson, D. E., Wood, L. C., Kwong, L. H., Moser, A. H. and Grunfeld, C. (1994). Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine. Metabolism, 43, 450-454.
12. O'Meara, N., Devery, R., Owens, D., Collins, P., Johnson, A. and Tomkin, G. H. (1991). Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models. Diabetologia, 34, 139-143.
13. Martins, I. J., Sainsbury, A. J., Mamo, J. C. and Redgrave, T. G. (1994). Lipid and apoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on clearance of chylomicron-like emulsions in insulin-deficient rats. Diabetologia, 37, 238-246.
14. Gleeson, A., Anderton, K., Owens, D., Bennett, A., Collins, P., Johnson, A., White, D. and Tomkin, G. H. (1999). The Role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia, 42, 944-948.
15. White, D. A., Bennett, A. J., Billett, M. A. and Slater, A. M. (1998). The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein. Br. J. Nurt., 80, 219-229.
16. Taggart, C., Gibney, J., Owens, D., Collins, P., Johnson, A. and Tomkin, G. H. (1997). The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes. Diabetic Medicine, 14, 1051-1058.
17. Curtin, A., Deegan, P., Owens, D., Johnson, A., Collins, P. and Tomkin, G. H. (1996). Elevated triglyceride-rich lipoproteins in diabetes: a study of apo B48 Acta Diabetologica, 33, 205-210.
18. Markwell, M. A. K., Haas, S. M., Bieber, L. L. and Tolbert, N. E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem., 87, 206-210.
19. Karpe, F. and Hamsten, A. (1994). Determination of apolipoproteins B48 and B100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid. Res., 35, 1311-1317.
20. Strandberg, T. E., Salomaa, V. V., Vanhanen, H. T. and Miettinen, T. A. (1996). Association of fasting blood glucose with cholesterol absorption and synthesis in non-diabetic middle-aged men. Diabetes, 45, 755-761.
21. Gylling, H. and Miettinen, T. A. (1997). Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care, 20, 90-95.
22. Stange, E. F. and Dietschy, J. M. (1980). Cholesterol synthesis and low density lipoprotein uptake are regulated independently in rat small intestinal epithelium. Proc. Natl. Acad. Sci. USA, 80, 5739-5743.
23. Field, F. J., Born, E., Murthy, S. and Mathur, S. N. (1998). Caevolin is present in intestinal cells: role in cholesterol trafficking? J. Lipid. Res., 39, 1938-1950.
24. Van Greevenbroek, M. M., Robertus-Teunissen, M. G., Erkelens, D. W. and de Bruin, W. A. (1998). Participation of the microsomal triglyceride transfer protein in lipoprotein assembly in Caco-2 cells: interaction with dietary saturated and unsaturated fatty acids. J. Lipid. Res., 39, 173-185.
25. Martins, I. J., Mortimer, B.-C., Miller, J. and Redgrave, T. G. (1996). Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J. Lipid. Res., 37, 2696-2705.
26. Li, X., Catalina, F., Grundy, S. M. and Patel, S. (1996). Method to measure apolipoprotein B48 and B100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B48 relative to B100-containing lipoproteins. J. Lipid. Res., 37, 210-220.